MDxHealth SA (MDXH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]
MDxHealth SA - Ordinary Shares (MDXH)
Company Research
Source: Yahoo! Finance
Revenue Guidance: Raised 2024 guidance to $87-$89 million, reflecting over 25% year-over-year growth. Total Billable Volume: 22,795 tests, a 30% increase year-over-year. Tissue-Based Test Volume: Over 10,000 tests, a 36% increase year-over-year. Liquid-Based Test Volume: Exceeded 12,000 tests, a 24% increase year-over-year. Gross Profit: $14.3 million for Q3 2024, a 14% increase year-over-year. Gross Margin: 61.2% for Q3 2024, down from 64.9% in Q3 2023. Operating Loss: $6.1 million for Q3 2024, compared to $4.6 million in Q3 2023. Cash and Cash Equivalents: $49.3 million as of September 30, 2024. Pro Forma Cash Balance: $53.5 million after additional equity financing. Warning! GuruFocus has detected 4 Warning Signs with MDXH. Release Date: November 06, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript MDxHealth SA ( NASDAQ:MDXH ) reported a 21% year-over-year revenue growth for Q3 2024, with revenues reac
Show less
Read more
Impact Snapshot
Event Time:
MDXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXH alerts
High impacting MDxHealth SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
MDXH
News
- MDxHealth SA (NASDAQ: MDXH) had its price target lowered by analysts at Piper Sandler from $8.00 to $6.00. They now have an "overweight" rating on the stock.MarketBeat
- MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024GlobeNewswire
- What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings [Yahoo! Finance]Yahoo! Finance
- MDxHealth SA (NASDAQ: MDXH) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $7.00 price target on the stock.MarketBeat
- MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6GlobeNewswire
MDXH
Earnings
- 11/6/24 - Miss
MDXH
Sec Filings
- 11/14/24 - Form SC
- 11/6/24 - Form 6-K
- 10/29/24 - Form 6-K
- MDXH's page on the SEC website